Azacitidine For
Common brands: Azacitidine, Azacitidine Azacitidine, Onureg, Vidaza, Venclexta
Top reporter: Accord Healthcare Inc.
Nucleoside Metabolic Inhibitor [EPC]BCL-2 Inhibitor [EPC]Azole Antifungal [EPC]Xanthine Oxidase Inhibitor [EPC]Corticosteroid [EPC]
17,483
Total Reports
12,582
Serious Reports
5,840
Death Reports
30
Reported Reactions
Death Report Ratio: High (33.40%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Azacitidine For.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | FEBRILE NEUTROPENIA | 1,925 | |
| 2 | DEATH | 1,821 | |
| 3 | OFF LABEL USE | 1,464 | |
| 4 | MYELOSUPPRESSION | 1,358 | |
| 5 | NEUTROPENIA | 1,306 | |
| 6 | ACUTE MYELOID LEUKAEMIA | 1,261 | |
| 7 | PNEUMONIA | 1,032 | |
| 8 | DRUG INEFFECTIVE | 985 | |
| 9 | PYREXIA | 956 | |
| 10 | THROMBOCYTOPENIA | 952 | |
| 11 | ANAEMIA | 765 | |
| 12 | INFECTION | 657 | |
| 13 | SEPSIS | 634 | |
| 14 | PANCYTOPENIA | 616 | |
| 15 | PLATELET COUNT DECREASED | 566 | |
| 16 | WHITE BLOOD CELL COUNT DECREASED | 466 | |
| 17 | NAUSEA | 464 | |
| 18 | ACUTE MYELOID LEUKAEMIA RECURRENT | 434 | |
| 19 | CYTOPENIA | 432 | |
| 20 | DIARRHOEA | 422 | |
| 21 | NEUTROPHIL COUNT DECREASED | 421 | |
| 22 | DISEASE PROGRESSION | 409 | |
| 23 | SEPTIC SHOCK | 370 | |
| 24 | FATIGUE | 339 | |
| 25 | MYELODYSPLASTIC SYNDROME | 328 | |
| 26 | ASTHENIA | 305 | |
| 27 | TUMOUR LYSIS SYNDROME | 296 | |
| 28 | VOMITING | 275 | |
| 29 | COVID-19 | 256 | |
| 30 | RESPIRATORY FAILURE | 256 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.